Suchergebnisse - "Weinreich, David M"

PubPharm (91)

31

Real-world Effectiveness of Casirivimab and Imdevimab in Patients With COVID-19 in the Ambulatory Setting: An Analysis of Two Large US National Claims Databases

enthalten in: bioRxiv.org | 2022

von Wei, W. | Murdock, D. | Jalbert, J. | +5

32

Survival with Cemiplimab in Recurrent Cervical Cancer

enthalten in: The New England journal of medicine | 2022

von Tewari, K. | Monk, B. | Vergote, I. | +133

CommentIn: Nat Rev Clin Oncol. 2022 Apr;19(4):220. - PMID 35217780

33

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection : A Randomized Clinical Trial

enthalten in: JAMA | 2022

von O'Brien, M. | Forleo-Neto, E. | Sarkar, N. | +136

UpdateOf: medRxiv. 2021 Sep 18;:. - PMID 34159343

34

Casirivimab and imdevimab for the treatment of hospitalized patients with COVID-19

enthalten in: bioRxiv.org | 2022

von Somersan-Karakaya, S. | Mylonakis, E. | Menon, V. | +29

35

Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)

enthalten in: Respiratory medicine | 2022

von Bateman, E. | Khan, A. | Xu, Y. | +8

CommentOn: Respir Med. 2022 Jan;191:105991. - PMID 35090688

36

Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study

enthalten in: The Journal of allergy and clinical immunology | 2022

von Gevaert, P. | De Craemer, J. | De Ruyck, N. | +19

37

Repeat Subcutaneous Administration of REGEN-COV® in Adults is Well-Tolerated and Prevents the Occurrence of COVID-19

enthalten in: bioRxiv.org | 2021

von Isa, F. | Forleo-Neto, E. | Meyer, J. | +27

38

Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention

enthalten in: bioRxiv.org | 2021

von O’Brien, M. | Forleo-Neto, E. | Musser, B. | +33

39

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

enthalten in: The New England journal of medicine | 2021

von Bacharier, L. | Maspero, J. | Katelaris, C. | +123

CommentIn: N Engl J Med. 2021 Dec 9;385(24):2297-2298. - PMID 34879454

40

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Simões, E. | Forleo-Neto, E. | Geba, G. | +20

CommentIn: Clin Infect Dis. 2021 Dec 6;73(11):e4409-e4410. - PMID 32640025